Podcasts about ischemic stroke

In this standout episode of Next Steps 4 Seniors: Conversations on Aging, we’re bringing back an audience favorite: our eye-opening interview with Nurse Practitioner Liz Jackson from Henry Ford Hospital. Liz breaks down the B.E.F.A.S.T. method for spotting stroke symptoms early, dives into the different types of strokes, and explains why timing is everything when it comes to treatment. We also tackle the red flags of heart attacks, the sneaky signs of vascular disease (yes, even leg cramping!), and how managing conditions like high blood pressure and diabetes can be game-changers. Early detection = lives saved. This episode is packed with info that could protect you or someone you love. Every week brings two ways to grow: Tuesdays dive into the physical next steps with real-life guidance for seniors and families, and Fridays uplift the heart with spiritual and emotional next steps—encouragement, faith, and hope for the journey ahead. To learn more about Next Steps 4 Seniors, contact us at 248-651-5010 or visit us online at www.nextsteps4seniors.com Find us on YouTube at https://www.youtube.com/@nextsteps4seniorsLearn more : https://omny.fm/shows/next-steps-4-seniors-with-wendy-jonesSee omnystudio.com/listener for privacy information.

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from January 31-February 6, 2026.

Recently, actor Donald Glover announced that he had a stroke, so today Ali and Asif start off by discussing Glover's career (1:16). They start off by discussing his early background and getting his break writing for ‘30 Rock'. They then talk about his breakthrough role on ‘Community' and other acting roles such as Lando Carlissian in ‘Solo: A Star Wars Story'. Ali then speaks about Donald Glover's alternate career as rapper “Childish Gambino. Finally they discuss Glover's critically acclaimed show ‘Atlanta'. Then Ali asks Asif about ischemic strokes (30:09) (and how they are different from brain bleeds). Asif talks about what strokes are as well as how common they are. He talks about the risk factors, causes as well what people need to be looking for regarding symptoms (using the acronym B.E.F.A.S.T.). Asif then goes over how strokes are diagnosed and treated. Finally Ali asks Asif about Glover stating he had a “hole in his heart” and how that might be related to his stroke. The opinions expressed are those of the hosts, and do not reflect those of any other organizations. This podcast and website represents the opinions of the hosts. The content here should not be taken as medical advice. The content here is for entertainment and informational purposes only, and because each person is so unique, please consult your healthcare professional for any medical questions. Music courtesy of Wataboi and 8er41 from PixabayContact us at doctorvcomedian@gmail.comShow Notes:Childish Gambino Freestyles Over the 5 Fingers of Death on #SwayInTheMorning | Sway's Universe: https://www.youtube.com/watch?v=Aw2kaBQMocoEvery Episode of ‘Atlanta,' Ranked: https://www.theringer.com/2022/11/11/tv/atlanta-fx-episodes-ranked-best-worst-seasonDonald Glover Reveals Stroke And “Hole In My Heart” Forced Him To Cancel 2024 Tour: https://deadline.com/2025/11/donald-glover-stroke-hole-heart-forced-cancel-tour-1236626789/Ischemic Stroke: https://www.ncbi.nlm.nih.gov/books/NBK499997/B.E. F.A.S.T. to Spot a Stroke: https://www.universityhealth.com/blog/be-f-a-s-t-to-spot-a-strokePatent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence: https://www.ahajournals.org/doi/10.1161/STROKEAHA.123.040546 Hosted on Acast. See acast.com/privacy for more information.

Commentary by Dr.  Jian'an Wang.

After an ischemic stroke, Jason Hellyer transformed his life — quitting alcohol, losing weight, and finding peace through change. The post Overcoming Ischemic Stroke Through Lifestyle Change: Jason Hellyer's Wake-Up Call appeared first on Recovery After Stroke.

Commentary by Dr. Yutao Guo.

References Endocrinology. 2018 Nov 15;160(1):205–219Int J Mol Sci. 2018 Jul 21;19(7):2124International Journal of Biological Macromolecules 2023.Volume 253, Part 5, 31 December. 27042Dylan, B. 1973. Knocking on Heaven's Doorhttps://music.youtube.com/watch?v=z4R5crZylQ0&si=5ZDmgJ4Zh8_h3F9aHunter/Garcia. 1971. Not Fade Away/Goin Down the Roadhttps://music.youtube.com/watch?v=pvcb1mkihho&si=8jR1uuARxBBHssZ-

We are amidst a paradigm shift in the emergency management of acute ischemic stroke. The traditional way of categorizing ischemic strokes as 'minor' vs 'major' is no longer relevant to what we do in the ED. It's now about 'disabling' vs 'non-disabling' strokes. And this is no small change. This categorization dictates urgency of ED work-up and treatments, imaging choices, treatment decisions and goals of care. In this Part 1 or our 2-part main episodes EM Cases podcast series on management of ischemic stroke with Dr. Walter Himmel and Dr. Katie Lin, we answer questions like: How can we best rapidly determine if an ischemic stroke is disabling or non-disabling at the bedside? In what ways are 'wake up strokes' managed uniquely and what's the latest thinking on their pathophysiology? How should we best prioritize imaging depending on timing, geography and resources? How do we best predict large vessel occlusion amenable to endovascular therapy (EVT) at the bedside? How can we efficiently establish goals of care at the bedside to inform our emergency decision making around strokes? Which is better for thrombolysis in ischemic stroke - Tenecteplase or Alteplase? How have contraindications to IV thrombolysis changed over the last decade? When should we consider bridge therapy with EVT after IV thrombolysis? What are 4 key items the ED physician should have ready for the stroke neurologist on the first call? and many more... If you enjoy EM Cases content please consider a donation to help support ongoing FOAMed here: https://emergencymedicinecases.com/donation/

ReferencesCells. 2023 Mar 14;12(6):896Arteriosclerosis, Thrombosis, and Vascular Biology 2019. Volume 39, Issue 3, March:432-445Beethoven, LV. 1809. The Emperor Piano Concerto #5. in E flat Major. Op 73.https://music.youtube.com/watch?v=kiW-QnQzN9Y&si=xBR59nceJWhZapjF

ReferencesProc Natl Acad Sci U S A. 2023 Jan30;120(6):e2219630120.Cells. 2023 Mar 14;12(6):896Guerra, DJ. 2025. Unpublished LecturesHunter, R. 1974 Tales of the Great Rum Runnershttps://music.youtube.com/watch?v=E7Dc_cJQzKw&si=EpCSXN61dFWr5K0ZIbid. Dry Dusty Road.https://music.youtube.com/watch?v=Jj7VoM6LvVw&si=U1geVxRp_-5ZYtFRMozart, WA, 1778. Concerto for Flute Harp and Orchestra in C Major K.299https://music.youtube.com/watch?v=nheif2BuFz0&si=NKLWDFAzlA8ztX8e

ReferencesProc Natl Acad Sci U S A. 2023 Jan30;120(6):e2219630120.Curr Hypertens Rep. 2018 Mar 19;20(3):20. FEBS Open Bio. 2022 Dec 1;13(1):185–194Biophys J. 2023 Apr 24;122(12):2381–2382 Lamb et al. 1970. Chicago II.https://open.spotify.com/album/0PRgsdDXQ8QPaDUetVF7yN?si=w4rzfSUkSlmq03nqYXDNlg

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Impact of Food Desert Residence on Ischemic Stroke and Hospitalization Risk in Atrial Fibrillation Patients.

November 2025 Journal Club Podcast Title: Thrombectomy for Patients With Large-Volume Ischemic Stroke: A Systematic Review and Meta-Analysis of 6 Randomized Trials To read journal article: https://journals.lww.com/neurosurgery/fulltext/2025/11000/thrombectomy_for_patients_with_large_volume.5.aspx Author: Mark Harrigan Guest Faculty: David Altschul Moderator: Zachary Sorrentino Committee Co-Chair: Kimberly Hoang

Send us a textDr. Adam Rogers, MD is Chief Executive Officer of NervGen Pharma Corp. ( https://nervgen.com/ ) a clinical-stage biotech company dedicated to developing innovative treatments to enable nervous system repair in the settings of traumatic injury and disease. NervGen's lead drug candidate, NVG-291, is being evaluated in mid stage clinical trials in an initial target indication, spinal cord injury. NervGen has initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury.Dr. Rogers is a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous, and previously co-founded and served as CEO of Hemera Biosciences, a clinical stage gene therapy biotech company targeting dry age-related macular degeneration where he oversaw all aspects of the company until the Hemera assets were acquired in December 2020 by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.From 2001 to 2020 Dr. Rogers served as an Assistant Professor of Ophthalmology at the New England Eye Center of Tufts Medical Center (Boston, MA). Dr. Rogers has published 29 articles in peer reviewed journals and co-authored two textbooks and numerous chapters in major ophthalmic textbooks. Since 2007 he has served on the board of One Family Inc., an organization whose mission is to end homelessness in Massachusetts. He is a member of the Emory University Board of Trustees. Dr. Rogers has a MD from Emory College and Emory School of Medicine.#SpinalCordInjury #SCI #IschemicStroke #AmyotrophicLateralSclerosis #ALS #NervGen #Rehabilitation #RegenerativeMedicine #RegenerativeBiology #ChondroitinSulfateProteoglycans #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation.  show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00439-8/fulltext  

Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation.  Read the related article in The Lancet.  Disclosures can be found at Neurology.org.   

Send us a textIn this episode of MedStar Health DocTalk, host Debra Schindler speaks with Dr. Othman Abdul-Malak, MD, MSC, a vascular expert, to break down the what carotid artery disease is, and how it can lead to stroke, mini-strokes (TIAs), and sudden vision loss. Learn how to recognize early warning signs—like facial droop, arm weakness, or sudden speech problems—and why acting fast can save brain function. Dr. Abdul-Malak also explains:·       The difference between ischemic and embolic strokes·       What amaurosis fugax means ·       Why age, heart disease, and cholesterol put you at greater risk·       When NOT to take aspirinThis episode is a must-listen for anyone interested in stroke prevention, vascular health, or caring for aging loved ones. Time is brain. Know the signs. Act fast.Subscribe for more expert-led episodes.To make an appointment with Dr. Abdul Malak, call 443-777-1900. If you would like to provide feedback on this podcast or get more information when carotid artery disease or treatment options, send me an to DocTalk@medstar.net For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Send us a textDr. Laiya Carayannopoulos & Dr. Mike Fralick connect to bring you another crossover episode, this time covering new studies on therapies for bronchiectasis and posterior circulation stroke. Take a listen and let us know what you think! Do you ever feel like you can't get ahead of charting? Freed AI has an AI driven scribe for you! You can try Freed for free right now by going to getfreed.ai. Listeners can use the INTERN50 code for $50 off their first month!Support the show

Send us a textWelcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast. This week, Dr. Mike Fralick and special guest Dr. Laiya Carayannopoulos from the Intern at Work Podcast and our Medicine Pods collaboration discuss two recent papers: the use of brensocatib (a DPP-1 inhibitor) to treat bronchiectasis, and the effect of alteplase administered 4.5 to 24 hours after stroke in patients with mild posterior circulation stroke who did not receive thrombectomy. Two papers, here we go!Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (0:00 – 12:46)Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours (12:47 – 24:55)And for the Good Stuff (24:56 – 26:08):Medicine Pods qMonthly newsletter Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Interview with Steven J. Warach, MD, PhD, author of Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

Interview with Steven J. Warach, MD, PhD, author of Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

In this standout episode of Next Steps 4 Seniors: Conversations on Aging, we’re bringing back an audience favorite: our eye-opening interview with Nurse Practitioner Liz Jackson from Henry Ford Hospital. Liz breaks down the B.E.F.A.S.T. method for spotting stroke symptoms early, dives into the different types of strokes, and explains why timing is everything when it comes to treatment. We also tackle the red flags of heart attacks, the sneaky signs of vascular disease (yes, even leg cramping!), and how managing conditions like high blood pressure and diabetes can be game-changers. Early detection = lives saved. This episode is packed with info that could protect you or someone you love. Listen now on your favorite podcast platform! Follow us on Facebook and Instagram @ConversationsOnAging Visit nextsteps4seniors.com and our foundation at nextsteps4seniorsfoundation.org Questions or ideas? Call 248-651-5010 or email hello@nextsteps4seniors.com Sponsorship inquiries: marketing@nextsteps4seniors.com Sponsored by Aeroflow Urology: You could qualify to receive incontinence supplies at no cost through insurance—discreetly delivered to your door. Visit aeroflowurology.com/ns4s to check eligibility. (*Some exclusions apply.)Learn more : https://nextsteps4seniors.com/See omnystudio.com/listener for privacy information.

Dr. Dan Ackerman and Dr. Phillip Ferdinand discuss the impact smoking has on stroke risk.  Show reference: https://www.neurology.org/doi/10.1212/WN9.0000000000000003 

Dr. Dan Ackerman talks with Dr. Phillip Ferdinand about the association between smoking and young cryptogenic ischemic stroke. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org.

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

Dr. Tesha Monteith discusses the Headache Journal article, “Association of Migraine Treatments with Reduced Ischemic Stroke Risk: Evidence from Two Large-Scale Real-World Data Analyses.” Show reference:  https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14918

Dr. BJ Hicks and Dr. Aaron Shoskes discuss the rising incidence of ischemic stroke in young adults. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000213447   

Dr. BJ Hicks talks with Dr. Aaron Shoskes about the rising incidence of ischemic stroke in young adults. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

One month after ischemic stroke: Tony's journey reveals real recovery challenges, inspiring rehab tips, and key support for true healing progress! The post One Month After Ischemic Stroke: A Survivor's Guide to Recovery and Resilience appeared first on Recovery After Stroke.

In this episode of Next Steps 4 Seniors: Conversations on Aging, we sit down with Nurse Practitioner Liz Jackson from Henry Ford Hospital to discuss life-saving information on strokes, heart attacks, and vascular health. We break down the B.E.F.A.S.T. method for identifying stroke symptoms early, explore the different types of strokes, and highlight the urgency of seeking immediate medical attention. Elizabeth also shares insights on recognizing heart attack warning signs, managing key risk factors like high blood pressure and diabetes, and understanding how leg cramping may indicate vascular disease. Early detection and fast action can save lives—tune in to learn how you can protect yourself and your loved ones.

Welcome back Rounds Table Listeners!We are back today with a solo episode with Dr. Mike Fralick!This week, he will discuss a paper exploring the role of intravenous thrombolytic therapy in patients with minor ischemic stroke and intracranial vessel occlusion. Here we go!Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open-label, phase 3 superiority trial (0:00 – 6:18).And for the Good Stuff:Trial Files (6:18 – 7:59).Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePodsDo you ever feel like you can't get ahead of charting? Freed AI has an AI driven scribe for you! You can try Freed for free right now by going to getfreed.ai. Listeners can use the INTERN50 code for $50 off their first month!

Commentary by Dr.  Jian'an Wang

Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel, MD, PhD, of Erasmus University Medical Center discusses this and more with JAMA Deputy Editor Christopher C. Muth, MD. Related Content: Intra-Arterial Thrombolytics During Thrombectomy for Ischemic Stroke—End of the Story or a New Beginning? Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic Stroke

Discover how a near-death ischemic stroke caused by hypertrophic cardiomyopathy led to an extraordinary recovery journey filled with resilience. The post Surviving an Ischemic Stroke: Roderick Jefferson's Journey with Hypertrophic Cardiomyopathy and Recovery appeared first on Recovery After Stroke.

In the October 8, 2024, issue of JACC, Dr. Casper Bonison and colleagues present a study on the risks of ischemic stroke recurrence after PFO closure, revealing that while the four-year risk remains higher than the general population, it mirrors clinical trial findings. They emphasize the importance of careful patient selection and the need for further research into closure techniques and associated stroke risk factors.

Fred shares his story of surviving an ischemic stroke, heart attacks, and arthritis, focusing on resilience, recovery, and overcoming adversity. The post Surviving Ischemic Stroke, Heart Attacks, and Arthritis: Fred's Story of Resilience and Recovery appeared first on Recovery After Stroke.

Cerebral Venous Sinus Thrombosis: Symptoms and Causes Cerebral venous sinus thrombosis (CVST) is a rare but serious condition characterized by the formation of a blood clot in the dural venous sinuses, which drain blood from the brain. Understanding the symptoms and causes of CVST is crucial for timely diagnosis and treatment. Understanding Cerebral Venous Sinus […] The post Healing and Hope: Jenna Muscat's Ischemic Stroke Recovery appeared first on Recovery After Stroke.

Watch young stroke survivor Neetu Mehra's inspiring journey from ischemic stroke at 44 to resilience and recovery. Click to hear her powerful story! The post Young Stroke Survivor Neetu's Ischemic Stroke at 44: A Powerful Story of Recovery and Resilience appeared first on Recovery After Stroke.

Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss recent trials presented at the European Stroke Organization Conference. Show references:  Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy  Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III) Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE) Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference. Show references:  Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy  Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III) Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE) Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.

Management of stroke due to large vessel occlusion (LVO) has undergone unprecedented change in the past decade. Early identification and aggressive treatment are important in mitigating negative effects on patients' prognoses. In this episode, Allison Weathers, MD, FAAN, speaks with T. M. Leslie-Mazwi, MD, author of the article “Neurocritical Care for Patients With Ischemic Stroke,” in the Continuum June 2024 Neurocritical Care issue. Dr. Weathers is a Continuum® Audio interviewer and an associate chief medical information officer at Cleveland Clinic in Cleveland, Ohio. Dr. Leslie-Mazwi is a professor and chair in the department of neurology at the University of Washington in Seattle, Washington. Additional Resources Read the article: Neurocritical Care for Patients With Ischemic Stroke Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Transcript Full transcript available

Braydon Dymm, MD, is a board-certified neurologist and accomplished physician who specializes in cerebrovascular disease and stroke care. After graduating summa cum laude from the University of Detroit Mercy and earning his medical degree from Wayne State University School of Medicine, he completed his neurology residency at Michigan Medicine. Dr. Dymm recently finished an advanced fellowship in cerebrovascular neurology at Duke University Hospital. He has made significant research contributions with publications in respected journals like Neurology and Stroke. Currently, Dr. Dymm serves as a neurohospitalist in the Department of Neurology at Charleston Area Medical Center. His passion for advancing stroke care and medical education has established him as an emerging leader in the field. In this episode, we cover: - The differences between ischemic and hemorrhagic strokes, including causes and symptoms. - The critical of recognizing stroke symptoms quickly using the BFAST mnemonic. - Gender disparities in stroke incidence, with a focus on why women are more affected and have worse outcomes. - The role of high blood pressure and cholesterol in stroke risk and prevention strategies. - The effectiveness of exercise, diet, and stress management in reducing stroke risk. - Advances in stroke treatment, including the transition from TPA to tenecteplase for quicker administration. - The potential for new technologies, like continuous blood pressure monitors, to improve stroke prevention. Sign up to The Neuro Athletics Newsletter: https://bit.ly/3ewI5P0 Sponsors: - Momentous - Use code NEURO to get up to 32% off your first subscription order - https://www.livemomentous.com/ - Inside Tracker - Use code LOUISA20 for 20% off - https://insidetracker.com/louisa - ZocDoc- Use code NEURO - https://www.zocdoc.com/neuro Connect with Braydon Twitter: https://x.com/BraydonDymm My Socials: Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ (00:00) Preview and Intro (00:36) Introducing Dr. Braydon Dymm (01:08) Gender Disparities in Stroke? (02:28) Pathology of Ischemic Stroke (06:29) Small Vessel Strokes (09:56) Alzheimer's as Vascular Dementia (11:18) Managing Blood Pressure and Cholesterol (13:15) Role of Exercise in Stroke Prevention (14:22) Resistance Training and Dementia Prevention (18:13) Golden Hour in Stroke Treatment (20:07) Recognizing Stroke Symptoms with BE-FAST (24:47) Anticoagulants vs. Antiplatelets (25:56) Preventing Strokes with Blood Thinners (26:45) Hemorrhagic Strokes (29:36) Medication Differences for Stroke Types (32:58) Gender Differences in Stroke Outcomes (33:04) Challenges of Detecting Atrial Fibrillation (37:25) Future Technologies for Stroke Prevention (41:03) Post-Stroke Depression Learn more about your ad choices. Visit megaphone.fm/adchoices

Braydon Dymm, MD, is a board-certified neurologist and accomplished physician who specializes in cerebrovascular disease and stroke care.After graduating summa cum laude from the University of Detroit Mercy and earning his medical degree from Wayne State University School of Medicine, he completed his neurology residency at Michigan Medicine. Dr. Dymm recently finished an advanced fellowship in cerebrovascular neurology at Duke University Hospital. He has made significant research contributions with publications in respected journals like Neurology and Stroke. Currently, Dr. Dymm serves as a neurohospitalist in the Department of Neurology at Charleston Area Medical Center.His passion for advancing stroke care and medical education has established him as an emerging leader in the field. In this episode, we cover:The differences between ischemic and hemorrhagic strokes, including causes and symptoms.The critical of recognizing stroke symptoms quickly using the BFAST mnemonic.Gender disparities in stroke incidence, with a focus on why women are more affected and have worse outcomes.The role of high blood pressure and cholesterol in stroke risk and prevention strategies.The effectiveness of exercise, diet, and stress management in reducing stroke risk.Advances in stroke treatment, including the transition from TPA to tenecteplase for quicker administration.The potential for new technologies, like continuous blood pressure monitors, to improve stroke prevention.Sign up to The Neuro Athletics Newsletter: https://bit.ly/3ewI5P0Connect with BraydonTwitter: https://x.com/BraydonDymmMy Socials:Instagram: https://www.instagram.com/louisanicola_/Twitter : https://twitter.com/louisanicola_Sponsors for today's episode:Momentous - Use code NEURO to get 20%  off your first subscription order - code NEURO:  https://www.livemomentous.com/Inside Tracker - Use code LOUISA20 for 20% off - https://insidetracker.com/louisaZocDoc- Use code NEURO - https://www.zocdoc.com/neuro(00:00) Preview and Intro(00:36) Introducing Dr. Braydon Dymm(01:08) Gender Disparities in Stroke?(02:28) Pathology of Ischemic Stroke(06:29) Small Vessel Strokes(09:56) Alzheimer's as Vascular Dementia(11:18) Managing Blood Pressure and Cholesterol(13:15) Role of Exercise in Stroke Prevention(14:22) Resistance Training and Dementia Prevention(18:13) Golden Hour in Stroke Treatment(20:07) Recognizing Stroke Symptoms with BFAST(24:47) Anticoagulants vs. Antiplatelets(25:56) Preventing Strokes with Blood Thinners(26:45) Hemorrhagic Strokes(29:36) Medication Differences for Stroke Types(32:58) Gender Differences in Stroke Outcomes(33:04) Challenges of DeThe Neuro Athletics Newsletter Instagram: @louisanicola_Twitter : @louisanicola_YouTube: @Louisa NicolaThe Neuro Experience Podcast is proud to have hosted: Dr Andrew Huberman, Dr Gabrielle Lyon, Dr Layne Norton, Thomas DeLauer, Shawn Stevenson, Dr. Rocio Salas-Whalen, Saad Alam, Uma Naidoo, Dr. Lanna Cheuck, Angela Lee Pucci, Jillian Turecki, Dr. Jordan Feigenbaum, Dr. Darren Candow, Dr. Sue Varma, Evy Poumpouras, Dr Casey Means, Renee Deehan, Dr Chris Palmer, Dr Charles Brenner.

Interview with Urs Fischer, MD, MSc, author of Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation

Shane Duffiney was in a car crash that damaged the blood vessels in his neck causing an ischemic stroke at 42 years of age. The post Ischemic Stroke Recovery Story – Shane Duffiney appeared first on Recovery After Stroke.

Symptoms of stroke – weakness, facial droop, slurred speech. vision loss, vertigo, ataxia, confusion or changes to mental status.   The “typical” stroke workup – blood glucose level, CTH non-con, CTA head/neck, CT Perfusion, CBC BMP Troponin EKG CXR and Coags.  Common stroke mimics – hypoglycemia, drug/alcohol intoxication, Bell's palsy, aortic dissection, complex migraines, and […]

Bear Herbert is a stroke survivor with speech challenges and surreal out-of-body experiences, offering unique insights into his journey. The post Multiple Ischemic Stroke Recovery – Bear Herbert appeared first on Recovery After Stroke.

In this episode, we review the role and indications of thrombolytics in acute ischemic stroke. The efficacy, safety, administration considerations, and cost between alteplase and tenecteplase are compared and contrasted. Key Concepts Alteplase (Activase) is a recombinant DNA version of human TPA (tissue plasminogen activator). Tenecteplase (TNKase) is similar to human TPA except it has three amino acid changes that result in a longer half-life and higher fibrin specificity. In patients with stroke, alteplase is given as a bolus followed by a 60-minute infusion. Tenecteplase is given as an IV bolus without the need for an infusion due to its longer half-life. Tenecteplase is at least as safe and effective as alteplase in acute ischemic stroke (with some studies showing greater benefit with tenecteplase). In patients with acute ischemic stroke who are candidates for mechanical thrombectomy, thrombolytics (with alteplase or tenecteplase) will still be given in patients who meet inclusion criteria and have no exclusion criteria. References Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [published correction appears in Stroke. 2019 Dec;50(12):e440-e441]. Stroke. 2019;50(12):e344-e418. doi:10.1161/STR.0000000000000211 Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018;378(17):1573-1582. doi:10.1056/NEJMoa1716405 Kobeissi H, Ghozy S, Turfe B, et al. Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials. Front Neurol. 2023;14:1102463. Published 2023 Jan 23. doi:10.3389/fneur.2023.1102463